First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial
Karim Fizazi, Arun A. Azad, Nobuaki Matsubara et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY
Medicine: papers
Filters2 filters applied
Status
Study type
Corrected Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
Lacey J. Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · Randomised trial
Full textCC BY